Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (VTVT) and Apollo Endosurgery Inc (APEN)


Analysts fell to the sidelines weighing in on vTv Therapeutics (VTVT) and Apollo Endosurgery Inc (APEN) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

vTv Therapeutics (VTVT)

Northland Securities analyst Carl Byrnes maintained a Hold rating on vTv Therapeutics yesterday and set a price target of $3. The company’s shares closed yesterday at $2.

According to TipRanks.com, Byrnes is a 1-star analyst with an average return of -0.4% and a 29.6% success rate. Byrnes covers the Healthcare sector, focusing on stocks such as Adamas Pharmaceuticals, Flexion Therapeutics, and Heron Therapeutics.

Currently, the analyst consensus on vTv Therapeutics is a Hold with an average price target of $3.

See today’s analyst top recommended stocks >>

Apollo Endosurgery Inc (APEN)

In a report released yesterday, Suraj Kalia from Northland Securities maintained a Hold rating on Apollo Endosurgery Inc, with a price target of $3. The company’s shares closed yesterday at $3.32, close to its 52-week low of $3.02.

Kalia observed:

“We note that the first Dear Doc letter on Orbera came in around the company took an impact in Q3 & Q4 of 2017. However, the company had said on the Q4- 17 call that the publication of a post-approval registry paper on a concerted Physician education / engagement effort were all expected to help the company reinvigorate growth on the U.S. Orbera side. So far, it has been 6 quarters and Orbera seems to be on a downward trajectory. LAP-BAND biz came in @ $4.1M. However, we do not discuss this contribution as this is essentially a discontinued portion of the biz given the recent divestiture to ReShape LifeSciences.”

According to TipRanks.com, Kalia is a 5-star analyst with an average return of 13.6% and a 59.7% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Varex Imaging Corporation, and Obalon Therapeutics Inc.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Apollo Endosurgery Inc with a $4.25 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts